MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
  • HTML
    190.15 Kb
  • XML
    403.98 Kb
You must be logged in to use this functionality
Loading full text...

Full text loading...

1. Abdulla, S.,, R. Oberholzer,, O. Juma,, S. Kubhoja,, F. Machera,, C. Membi,, S. Omari,, A. Urassa,, H. Mshinda,, A. Jumanne,, N. Salim,, M. Shomari,, T. Aebi,, D. M. Schellenberg,, T. Carter,, T. Villafana,, M. A. Demoitié,, M. C. Dubois,, A. Leach,, M. Lievens,, J. Vekemans,, J. Ghen,, W. R. Ballou,, and M. Tanner. 2008. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N. Engl. J. Med. 359: 2533 2544.
1a. Achtman, A. H.,, P. C. Bull,, R. Stephens,, and J. Langhorne. 2005. Longevity of the immune response and memory to blood-stage malaria infection. Curr. Top. Microbiol. Immunol. 297: 71 102.
2. Acosta, C. J.,, C. M. Galindo,, D. Schellenberg,, J. J. Aponte,, E. Kahigwa,, H. Urassa,, J. R. Schellenberg,, H. Masanja,, R. Hayes,, A. Y. Kitua,, F. Lwilla,, H. Mshinda,, C. Menendez,, M. Tanner,, and P. L. Alonso. 1999. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania. Trop. Med. Int. Health 4: 368 376.
3. Aide, P.,, Q. Bassat,, and P. L. Alonso. 2007. Towards an effective malaria vaccine. Arch. Dis. Child. 92: 476 479.
4. Aikawa, M.,, J. R. Rabbege,, I. Udeinya,, and L. H. Miller. 1983. Electron microscopy of knobs in Plasmodium falciparum-infected erythrocytes. J. Parasitol. 69: 435 437.
5. Alkin, S. S. 2004. Monoclonal antibodies: the story of a discovery that revolutionized science and medicine. Nat. Rev. Immunol. 4: 153 156.
6. Alonso, P. L.,, T. Smith,, J. R. Schellenberg,, H. Masanja,, S. Mwankusye,, H. Urassa,, I. Bastos de Azevedo,, J. Chongela,, S. Kobero,, C. Menendez, et al. 1994. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344: 1175 1181.
7. Altman, L. K. 1987. Who Goes First? The Story of Self-Experimentation in Medicine. Random House, New York, NY.
8. Anonymous. 1989. AID's Malaria Vaccine Research Activities. General Accounting Office, Washington, DC.
9. Anonymous. 1975. Malaria vaccine on the horizon. Br. Med. J. 1: 231 232. (Editorial.)
10. Anonymous. 2007. Is malaria eradication possible? Lancet 370: 1459.
11. Anonymous. 1998, posting date. Miodrag Ristic Investigation File, 1963–67, 1980–92.
12. Anonymous. 1963. Obituary. Jules Freund 1890–1960. J. Immunol. 90: 331 336.
13. Anonymous. 1993. Retired prof convicted of fraud. Researcher to perform 300 hours of service, pay $50,000. http://www.illinimedia.com/di/archives/1993/February/22/prof.html. Illini Media Co. Champaign, IL.
14. Anonymous. 1993. Scientist accused of theft retains post. Science 260: 1415.
15. Aponte, J. J.,, P. Aide,, M. Renom,, I. Mandomando,, Q. Bassat,, J. Sacarlal,, M. N. Manaca,, S. Lafuente,, A. Barbosa,, A. Leach,, M. Lievens,, J. Vekemans,, B. Sigauque,, M. C. Dubois,, M. A. Demoitie,, M. Sillman,, B. Savarese,, J. G. McNeil,, E. Macete,, W. R. Ballou,, J. Cohen,, and P. L. Alonso. 2007. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 370: 1543 1551.
16. Arakawa, T.,, A. Komesu,, H. Otsuki,, J. Sattabongkot,, R. Udomsangpetch,, Y. Matsumoto,, N. Tsuji,, Y. Wu,, M. Torii,, and T. Tsuboi. 2005. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum. Infect. Immun. 73: 7375 7380.
17. Ardeshir, F.,, J. E. Flint,, and R. T. Reese. 1985. Expression of Plasmodium falciparum surface antigens in Escherichia coli. Proc. Natl. Acad. Sci. USA 82: 2518 2522.
18. Ardeshir, F.,, J. E. Flint,, S. J. Richman,, and R. T. Reese. 1987. A 75 kd merozoite surface protein of Plasmodium falciparum which is related to the 70 kd heat-shock proteins. EMBO J. 6: 493 499.
19. Arese, P.,, K. Ayi,, A. Skorokhod,, and F. Turrini,. 2006. Removal of early parasite forms from circulation as a mechanism of resistance against malaria in widespread red blood cell mutations, p. 25 53. In K. R. Dronamraju, and P. Arese (ed.), Malaria: Genetic and Evolutionary Aspects. Springer, New York, NY.
20. Aucouturier, J.,, S. Ascarateil,, and L. Dupuis. 2006. The use of oil adjuvants in therapeutic vaccines. Vaccine 24S2: S2/44 S42/45.
21. Avril, M.,, B. Gamain,, C. Lepolard,, N. Viaud,, A. Scherf,, and J. Gysin. 2006. Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. Microbes Infect. Inst. Pasteur 8: 2863 2871.
22. Babon, J. J.,, W. D. Morgan,, G. Kelly,, J. F. Eccleston,, J. Feeney,, and A. A. Holder. 2007. Structural studies on Plasmodium vivax merozoite surface protein-1. Mol. Biochem. Parasitol. 153: 31 40.
23. Ballou, W. R. 2007. Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine. Microbes Infect. Inst. Pasteur 9: 761 766.
24. Ballou, W. R.,, and C. P. Cahill. 2007. Two decades of commitment to malaria vaccine development: GlaxoSmithKline Biologicals. Am. J. Trop. Med. Hyg. 77: 289 295.
25. Ballou, W. R.,, S. L. Hoffman,, J. A. Sherwood,, M. R. Hollingdale,, F. A. Neva,, W. T. Hockmeyer,, D. M. Gordon,, I. Schneider,, R. A. Wirtz,, J. F. Young, et al. 1987. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 329: 1277 1281.
26. Bannister, L.,, A. Margos,, and J. Hopkins,. 2005. Making a home for Plasmodium post-genomics: ultrastructural organization of the blood stages, p. 24 49. In I. W. Sherman (ed.), Molecular Approaches to Malaria. ASM Press, Washington, DC.
27. Bannister, L.,, and G. H. Mitchell. 2003. The ins, outs and roundabouts of malaria. Trends Parasitol. 19: 209 213.
28. Bannister, L. H.,, G. A. Butcher,, E. D. Dennis,, and G. H. Mitchell. 1975. Structure and invasive behaviour of Plasmodium knowlesi merozoites in vitro. Parasitology 71: 483 491.
29. Barcia, J. J. 2007. The Giemsa stain: its history and applications. Int. J. Surg. Pathol. 15: 292 296.
30. Bardes, C. L. 2008. Pale Faces. The Masks of Anemia. Bellevue, New York, NY.
31. Barnwell, J. W.,, R. J. Howard,, H. G. Coon,, and L. H. Miller. 1983. Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria. Infect. Immun. 40: 985 994.
32. Barnwell, J. W.,, R. J. Howard,, and L. H. Miller. 1982. Altered expression of Plasmodium knowlesi variant antigen on the erythrocyte membrane in splenectomized rhesus monkeys. J. Immunol. 128: 224 226.
33. Barnwell, J. W.,, M. E. Nichols,, and P. Rubinstein. 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med. 169: 1795 1802.
34. Baruch, D. I. 1999. Adhesive receptors on malaria-parasitized red cells. Baillieres Best Pract. Res. Clin. Haematol. 12: 747 761.
35. Baruch, D. I.,, B. Gamain,, and L. H. Miller. 2003. DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses. Infect. Immun. 71: 4536 4543.
36. Baruch, D. I.,, B. L. Pasloske,, H. B. Singh,, X. Bi,, X. C. Ma,, M. Feldman,, T. F. Taraschi,, and R. J. Howard. 1995. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82: 77 87.
37. Baumler, E. 1984. Paul Ehrlich, Scientist for Life. Holmes and Meier, New York, NY.
38. Beaudoin, R. L. 1977. Should cultivated exoerythrocytic parasites be considered as a source of antigen for a malaria vaccine? Bull. W. H. O. 55: 373 376.
39. Beaudoin, R. L.,, C. P. Strome,, F. Mitchell,, and T. A. Tubergen. 1977. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp. Parasitol. 42: 1 5.
40. Beaudoin, R. L.,, C. P. Strome,, T. A. Tubergen,, and F. Mitchell. 1976. Plasmodium berghei berghei: irradiated sporozoites of the ANKA strain as immunizing antigens in mice. Exp. Parasitol. 39: 438 443.
40a. Bejon, P.,, J. Lusingu,, A. Olotu,, A. Leach,, M. Lievens,, J. Vekemans,, S. Mshamu,, T. Lang,, J. Gould,, M. C. Dubois,, M. A. Demoitié,, J. F. Stallaert,, P. Vansadia,, T. Carter,, P. Njunguna,, K. O. Awuondo,, A. Malabeja,, O. Abdul,, S. Gesase,, N. Mturi,, C. J. Drakeley,, B. Savarese,, T. Villafana,, W. R. Ballou,, J. Cohen,, G. M. Riley,, M. M. Lemnge,, K. Marsh,, and L. von Seidlein. 2008. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N. Engl. J. Med. 359: 2521 2532.
41. Belnoue, E.,, F. T. Costa,, T. Frankenberg,, A. M. Vigario,, T. Voza,, N. Leroy,, M. M. Rodrigues,, I. Landau,, G. Snounou,, and L. Renia. 2004. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172: 2487 2495.
42. Biagini, G. A.,, P. M. O'Neill,, P. G. Bray,, and S. A. Ward. 2005. Current drug development portfolio for antimalarial therapies. Curr. Opin. Pharmacol. 5: 1 6.
43. Biello, D. 5 March 2008, posting date. Lending a helping arm: volunteers risk malaria to test vaccine. Sci. Am. Online
44. Bignami, A.,, and G. Bastianelli. 1890. Observazioni suile febbri malariche estive-autunnali. Rif. Medi. 232: 1334 1335.
45. Biswas, P. 1999. Patterns of parasitemia, antibodies, complement and circulating immune complexes in drug-suppressed simian Plasmodium knowlesi malaria. Indian J. Malariol. 36: 33 41.
46. Bitragunta, S.,, M. V. Murhekar,, Y. J. Hutin,, P. P. Penumur,, and M. D. Gupte. 2008. Persistence of diphtheria, Hyderabad, India, 2003–2006. Emerg. Infect. Dis. 14: 1144 1146.
47. Blackman, M. J.,, T. J. Scott-Finnigan,, S. Shai,, and A. A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180: 389 393.
48. Boffey, P. M. 1984. Malaria vaccine is near, U.S. health officials say. New York Times. New York, NY.
49. Boffey, P. M. 1988. U.S. Malaria Program, roiled by harassment dispute, faces new security. New York Times. New York, NY.
50. Bojang, K. A.,, S. K. Obaro,, U. D'Alessandro,, S. Bennett,, P. Langerock,, G. A. Targett,, and B. M. Greenwood. 1998. An efficacy trial of the malaria vaccine SPf66 in Gambian infants—second year of followup. Vaccine 16: 62 67.
51. Boutlis, C. S.,, E. M. Riley,, N. M. Anstey,, and J. B. de Souza. 2005. Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination. Curr. Top. Microbiol. Immunol. 297: 145 185.
52. Brattig, N. W.,, K. Kowalsky,, X. Liu,, G. D. Burchard,, F. Kamena,, and P. H. Seeberger. 2008. Plasmodium falciparum glycosylphosphatidylinositol toxin interacts with the membrane of non-parasitized red blood cells: a putative mechanism contributing to malaria anemia. Microbes Infect. Inst. Pasteur 10: 885 891.
53. Bray, R. S. 1976. Vaccination against Plasmodium falciparum: a negative result. Trans. R. Soc. Trop. Med. Hyg. 70: 258.
54. Brock, T. 1999. Robert Koch, a Life in Medicine. ASM Press, Washington, DC.
55. Brooke, J. 1993. Colombian physician challenges malaria on the home front. New York Times, New York, NY.
56. Brown, E. M. 2000. Why Wagner-Jauregg won the Nobel prize for discovering malaria therapy for general paresis of the insane. Hist. Psychiatry 11: 371 382.
57. Brown, H. 2007. Obituary. Sir Ian Alexaner McGregor. Lancet 369: 134.
58. Brown, K. N. 1973. Antibody-induced variation in malaria parasites. Nature 242: 49 50.
59. Brown, K. N., 1976. Resistance to malaria, p. 268 295. In S. Cohen, and E. Sadun (ed.), Immunology of Parasitic Infections. Blackwell, Oxford, United Kingdom.
60. Brown, K. N.,, and I. N. Brown. 1965. Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature 208: 1286 1288.
61. Brown, K. N.,, I. N. Brown,, and L. A. Hills. 1970. Immunity to malaria. I. Protection against Plasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund's adjuvant. Exp. Parasitol. 28: 304 317.
62. Brown, K. N.,, and J. Williamson. 1962. Antigens of brucei trypanosomes. Nature 194: 1253 1255.
63. Brown, P. 1991. Trials and tribulations of a malaria vaccine: one of the most hopeful candidates for a malaria vaccine emerged from an area where the disease is endemic. Its results have raised expectations and scientific controversy. New Sci. 129: 18 20.
64. Bueding, E. 1962. Comparative biochemistry of parasitic helminths. Comp. Biochem. Physiol. 4: 343 351.
65. Butcher, G. A.,, and S. Cohen. 1972. Antigenic variation and protective immunity in Plasmodium knowlesi malaria. Immunology 23: 503 521.
66. Butcher, G. A.,, S. Cohen,, and P. C. Garnham. 1970. Passive immunity in Plasmodium knowlesi malaria. Trans. R. Soc. Trop. Med. Hyg. 64: 850 856.
67. Butcher, G. A.,, G. H. Mitchell,, and S. Cohen. 1973. Mechanism of host specificity in malarial infection. Nature 244: 40 41. (Letter.)
68. Bynum, J.,, and C. Overy. 1998. The Beast in the Mosquito: the Correspondence of Ronald Ross and Patrick Manson. Rodopi, Amsterdam, The Netherlands.
69. Camus, D.,, and T. J. Hadley. 1985. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 230: 553 556.
70. Carter, R. 2002. Spatial simulation of malaria transmission and its control by malaria transmission blocking vaccination. Int. J. Parasitol. 32: 1617 1624.
71. Carter, R. 2001. Transmission blocking malaria vaccines. Vaccine 19: 2309 2314.
72. Carter, R.,, and D. H. Chen. 1976. Malaria transmission blocked by immunisation with gametes of the malaria parasite. Nature 263: 57 60.
73. Carter, R.,, R. W. Gwadz,, and I. Green. 1979. Plasmodium gallinaceum: transmission-blocking immunity in chickens. II. The effect of antigamete antibodies in vitro and in vivo and their elaboration during infection. Exp. Parasitol. 47: 194 208.
74. Carter, R.,, R. W. Gwadz,, and F. M. McAuliffe. 1979. Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations. Exp. Parasitol. 47: 185 193.
75. Carter, R.,, and D. C. Kaushal. 1984. Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. III. Changes in zygote surface proteins during transformation to mature ookinete. Mol. Biochem. Parasitol. 13: 235 241.
76. Cassier, M. 2005. Appropriatrion and commercialization of the Pasteur anthrax vaccine. Stud. Hist. Philos. Biol. Biomed. Sci. 36: 722 742.
77. Cates, L.,, S. James,, G. Jennings,, W. Hockmeyer,, and R. Ballou. 2003. External evaluation of the USAID Malaria Vaccine Development Project. U.S. Agency for International Development, Washington, DC.
78. Cavasini, C. E.,, L. C. Mattos,, A. A. Couto,, C. R. Bonini-Domingos,, S. H. Valencia,, W. C. Neiras,, R. T. Alves,, A. R. Rossit,, L. Castilho,, and R. L. Machado. 2007. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? Trans. R. Soc. Trop. Med. Hyg. 101: 1042 1044.
79. Chakravarty, S.,, I. A. Cockburn,, S. Kuk,, M. G. Overstreet,, J. B. Sacci,, and F. Zavala. 2007. CD8 + T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13: 1035 1041.
80. Chang, K. H.,, and M. M. Stevenson. 2004. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during bloodstage malaria. Int. J. Parasitol. 34: 1501 1516.
81. Chatterjee, S.,, J. L. Perignon,, E. Van Marck,, and P. Druilhe. 2006. How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations. J. Postgrad. Med. 52: 321 324.
82. Chen, Q.,, A. Heddini,, A. Barragan,, V. Fernandez,, S. F. Pearce,, and M. Wahlgren. 2000. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J. Exp. Med. 192: 1 10.
83. Chen, Q.,, F. Pettersson,, A. M. Vogt,, B. Schmidt,, S. Ahuja,, P. Liljestrom,, and M. Wahlgren. 2004. Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes. Vaccine 22: 2701 2712.
84. Chernin, E. 1984. The malariatherapy of neurosyphilis. J. Parasitol. 70: 611 617.
85. Chitnis, C. E. 2001. Molecular insights into receptors used by malaria parasites for erythrocyte invasion. Curr. Opin. Hematol. 8: 85 91.
86. Clark, I. A.,, A. C. Allison,, and F. E. Cox, 1976. Protection of mice against Babesia and Plasmodium. Nature 259: 309 311.
87. Clark, I. A.,, E. J. Wills,, J. E. Richmond,, and A. C. Allison. 1977. Suppression of babesiosis in BCG–infected mice and its correlation with tumor inhibition. Infect. Immun. 17: 430 438.
88. Clyde, D. F. 1990. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies 1971–75. Bull. W. H. O. 68( Suppl. 1): 9 12.
89. Clyde, D. F. 1975. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 24: 397 401.
90. Clyde, D. F.,, H. Most,, and J. Vanderberg. 1973. Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266: 169 177.
91. Coatney, G. R.,, W. E. Collins,, M. Warren,, and P. G. Contacos. 1971. The Primate Malarias. U.S. Government Printing Office, Bethesda, MD.
92. Cochrane, A. H.,, R. Nussenzweig,, and E. Nardin,. 1980. Immunization against sporozoites, p. 163 202. In J. Kreier (ed.), Malaria, vol. 3. Academic Press, San Diego, CA.
93. Cockburn, I. A.,, M. J. Mackinnon,, A. O'Donnell,, S. J. Allen,, J. M. Moulds,, M. Baisor,, M. Bockarie,, J. C. Reeder,, and J. A. Rowe. 2004. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc. Natl. Acad. Sci. USA 101: 272 277.
94. Coggeshall, L. T. 1938. Plasmodium lophurae, a new species of malaria pathogenic for the domestic fowl. Am. J. Hyg. 27: 615 618.
95. Coggeshall, L. T.,, and M. Eaton. 1938. Complement fixation reaction in monkey malaria. J. Exp. Med. 66: 177 190.
96. Coggeshall, L. T.,, and H. Kumm. 1937. Demonstration of passive immunity in experimental monkey malaria. J. Exp. Med. 66: 177 190.
97. Coggeshall, L. T.,, and H. Kumm. 1938. Effect of repeated superinfection upon the patency of immune serum of monkeys harboring chronic infections of Plasmodium knowlesi. J. Exp. Med. 68: 17 27.
98. Cohen, S. 1963. Gamma-globulin metabolism. Br. Med. J. 19: 202 206.
99. Cohen, S.,, and G. A. Butcher. 1970. Properties of protective malarial antibody. Nature 225: 732 734.
100. Cohen, S.,, G. A. Butcher,, and R. B. Crandall. 1969. Action of malarial antibody in vitro. Nature 223: 368 371.
101. Cohen, S.,, I. McGregor,, and S. Carrington. 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192: 733 737.
102. Collins, W. E. 2002. Nonhuman primate models. I. Nonhuman primate host-parasite combinations. Methods Mol. Med. 72: 77 84.
103. Collins, W. E. 2002. Nonhuman primate models. II. Infection of Saimiri and Aotus monkeys with Plasmodium vivax. Methods Mol. Med. 72: 85 92.
103a. Collins, W. E.,, and J. W. Barnwell. 2008. A helpful beginning for malaria vaccines. N. Engl. J. Med. 359: 2599 2601.
104. Collins, W. E.,, and G. M. Jeffery. 1999. A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am. J. Trop. Med. Hyg. 61: 20 35.
105. Collins, W. E.,, and G. M. Jeffery. 1999. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. Am. J. Trop. Med. Hyg. 61: 36 43.
106. Collins, W. E.,, and G. M. Jeffery. 1999. A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum. Am. J. Trop. Med. Hyg. 61: 44 48.
107. Collins, W. E.,, and G. M. Jeffery. 2007. Plasmodium malariae: parasite and disease. Clin. Microbiol. Rev. 20: 579 592.
108. Collins, W. E.,, G. M. Jeffery,, and J. M. Roberts. 2004. A retrospective examination of reinfection of humans with Plasmodium vivax. Am. J. Trop. Med. Hyg. 70: 642 644.
109. Collins, W. E.,, and G. M. Jeffrey. 2005. Plasmodium ovale: parasite and disease. Clin. Microbiol. Rev. 18: 570 581.
110. Collins, W. E.,, J. C. Skinner,, M. Pappaioanou,, J. R. Broderson,, N. S. Ma,, V. Filipski,, P. S. Stanfill,, and L. Rogers. 1988. Infection of Peruvian Aotus nancymai monkeys with different strains of Plasmodium falciparum, P. vivax, and P. malariae. J. Parasitol. 74: 392 398.
111. Cowman, A. F.,, and B. S. Crabb. 2006. Invasion of red blood cells by malaria parasites. Cell 124: 755 766.
112. Crandall, I.,, W. E. Collins,, J. Gysin,, and I. W. Sherman. 1993. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 90: 4703 4707.
113. Crandall, I.,, and I. W. Sherman. 1994. Antibodies to synthetic peptides based on band 3 motifs react specifically with Plasmodium falciparum (human malaria)-infected erythrocytes and block cytoadherence. Parasitology 108: 389 396.
114. Dahlback, M.,, T. S. Rask,, P. H. Andersen,, M. A. Nielsen,, N. T. Ndam,, M. Resende,, L. Turner,, P. Deloron,, L. Hviid,, O. Lund,, A. G. Pedersen,, T. G. Theander,, and A. Salanti. 2006. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration. PLoS Pathog. 2: e124.
115. Dame, J. B.,, J. L. Williams,, T. F. McCutchan,, J. L. Weber,, R. A. Wirtz,, W. T. Hockmeyer,, W. L. Maloy,, J. D. Haynes,, I. Schneider,, D. Roberts, et al. 1984. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225: 593 599.
116. Daubersies, P.,, B. Ollomo,, J. P. Sauzet,, K. Brahimi,, B. L. Perlaza,, W. Eling,, H. Moukana,, P. Rouquet,, C. de Taisne,, and P. Druilhe. 2008. Genetic immunisation by liver stage antigen 3 protects chimpanzees against malaria despite low immune responses. PLoS ONE 3: e2659.
117. Daubersies, P.,, A. W. Thomas,, P. Millet,, K. Brahimi,, J. A. Langermans,, B. Ollomo,, L. BenMohamed,, B. Slierendregt,, W. Eling,, A. Van Belkum,, G. Dubreuil,, J. F. Meis,, C. Guerin-Marchand,, S. Cayphas,, J. Cohen,, H. Gras-Masse,, and P. Druilhe. 2000. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat. Med. 6: 1258 1263.
118. Deane, L.,, J. Neto,, and I. Silveira. 1966. Experimental infection of a splenectomized squirrel monkey Saimiri sciureus. Trans. R. Soc. Trop. Med. Hyg. 60: 811 812.
119. Deans, A. M.,, S. Nery,, D. J. Conway,, O. Kai,, K. Marsh,, and J. A. Rowe. 2007. Invasion pathways and malaria severity in Kenyan Plasmodium falciparum clinical isolates. Infect. Immun. 75: 3014 3020.
120. Deans, J. 1984. Protective antigens of blood stage Plasmodium knowlesi parasites. Philos. Trans. R. Soc. Lond. Ser. B 307: 159 169.
121. Deans, J. A.,, T. Alderson,, A. W. Thomas,, G. H. Mitchell,, E. S. Lennox,, and S. Cohen. 1982. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin. Exp. Immunol. 49: 297 309.
122. Deans, J. A.,, A. M. Knight,, W. C. Jean,, A. P. Waters,, S. Cohen,, and G. H. Mitchell. 1988. Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen. Parasite Immunol. 10: 535 552.
123. Debre, P. 1998. Louis Pasteur. Johns Hopkins Press, Baltimore, MD.
124. de Kruif, P. 1926. Microbe Hunters. Harcourt Brace, San Diego, CA.
125. Dennis, E. D.,, G. H. Mitchell,, G. A. Butcher,, and S. Cohen. 1975. In vitro isolation of Plasmodium knowlesi merozoites using polycarbonate sieves. Parasitology 71: 475 481.
126. Desowitz, R. 2002. Federal Bodysnatchers and the New Guinea Virus. Norton, New York, NY.
127. Desowitz, R. 1991. The Malaria Capers. More Tales of Parasites and People, Research and Reality. Norton, New York, NY.
128. Diggs, C. L., 1980. Prospects for development of vaccines against Plasmodium falciparum infection, p. 299 315. In J. Kreier (ed.), Malaria, vol. 3. Academic Press, Inc., San Diego, CA.
129. Diggs, C. L.,, F. Hines,, and B. T. Wellde. 1995. Plasmodium falciparum: passive immunization of Aotus lemurinus griseimembra with immune serum. Exp. Parasitol. 80: 291 296.
130. Dobell, C. 1960. Antony van Leeuwenhoek and His “Little Animals”; Being Some Account of the Father of Protozoology and Bacteriology and His Multifarious Discoveries in These Disciplines. Dover, New York, NY.
131. Dobson, M. J. 1997. Contours of Death and Disease in Early Modern England. Cambridge University Press, Cambridge, United Kingdom.
132. Doolan, D.,, J. Dobano,, and J. K. Baird. 2009. Acquired immunity to malaria. Clin. Microbiol. Rev. 22: 13 36.
133. Doolan, D.,, and S. L. Hoffman. 2002. Nucleic acid vaccines against malaria. Chem. Immunol. 80: 308 321.
134. Doolan, D.,, and A. Stewart. 2007. Status of malaria R & D in 2007. Expert Rev. Vaccines 6: 903 905.
135. Doolan, D. L.,, R. C. Hedstrom,, W. O. Rogers,, Y. Charoenvit,, M. Rogers,, P. de la Vega,, and S. L. Hoffman. 1996. Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J. Biol. Chem. 271: 17861 17868.
136. Doolan, D. L.,, and S. L. Hoffman. 1997. Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections. Philos. Trans. R. Soc. Lond. Ser. B 352: 1361 1367.
137. Doolan, D. L.,, and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165: 1453 1462.
138. Doolan, D. L.,, and N. Martinez-Alier. 2006. Immune response to pre-erythrocytic stages of malaria parasites. Curr. Mol. Med. 6: 169 185.
139. Doolan, D. L.,, Y. Mu,, B. Unal,, S. Sundaresh,, S. Hirst,, C. Valdez,, A. Randall,, D. Molina,, X. Liang,, D. A. Freilich,, J. A. Oloo,, P. L. Blair,, J. C. Aguiar,, P. Baldi,, D. H. Davies,, and P. L. Felgner. 2008. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8: 4680 4694.
140. Doolan, D. L.,, M. Sedegah,, R. C. Hedstrom,, P. Hobart,, Y. Charoenvit,, and S. L. Hoffman. 1996. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8 + cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 183: 1739 1746.
141. Doolan, D. L.,, S. Southwood,, D. A. Freilich,, J. Sidney,, N. L. Graber,, L. Shatney,, L. Bebris,, L. Florens,, C. Dobano,, A. A. Witney,, E. Appella,, S. L. Hoffman,, J. R. Yates III,, D. J. Carucci,, and A. Sette. 2003. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. USA 100: 9952 9957.
142. Douradinha, B.,, M. R. van Dijk,, R. Ataide,, G. J. van Gemert,, J. Thompson,, J. F. Franetich,, D. Mazier,, A. J. Luty,, R. Sauerwein,, C. J. Janse,, A. P. Waters,, and M. M. Mota. 2007. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int. J. Parasitol. 37: 1511 1519.
143. Draper, S. J.,, A. C. Moore,, A. L. Goodman,, C. A. Long,, A. A. Holder,, S. C. Gilbert,, F. Hill,, and A. V. Hill. 2008. Effective induction of high-titer antibodies by viral vector vaccines. Nat. Med. 14: 819 821.
144. Druilhe, P.,, and J. W. Barnwell. 2007. Pre-erythrocytic stage malaria vaccines: time for a change in path. Curr. Opin. Microbiol. 10: 371 378.
145. Druilhe, P.,, and C. Marchand,. 1989. From sporozoite to liver stages: the saga of the irradiated sporozoite vaccine, p. 39 50. In K. P. W. McAdams (ed.), Frontiers of Infectious Diseases. New Strategies in Parasitology. Churchill Livingstone, London, United Kingdom.
146. Druilhe, P.,, L. Renia,, and D. Fidock,. 1998. Immunity to liver stages, p. 513 544. In I. W. Sherman (ed.), Malaria. Parasite Biology, Pathogenesis, and Protection. ASM Press, Washington, DC.
147. Dubos, R. 1976. Louis Pasteur, Free Lance of Science. Scribners Sons, New York, NY.
148. Duffy, M. F.,, A. Caragounis,, R. Noviyanti,, H. M. Kyriacou,, E. K. Choong,, K. Boysen,, J. Healer,, J. A. Rowe,, M. E. Molyneux,, G. V. Brown,, and S. J. Rogerson. 2006. Transcribed var genes associated with placental malaria in Malawian women. Infect. Immun. 74: 4875 4883.
149. Duffy, M. F.,, A. G. Maier,, T. J. Byrne,, A. J. Marty,, S. R. Elliott,, M. T. O'Neill,, P. D. Payne,, S. J. Rogerson,, A. F. Cowman,, B. S. Crabb,, and G. V. Brown. 2006. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 148: 117 124.
150. Duffy, P. E. 2007. Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia. Parasitology 134: 1877 1881.
151. Duffy, P. E.,, and M. Fried. 2005. Malaria in the pregnant woman. Curr. Top. Microbiol. Immunol. 295: 169 200.
152. Duraisingh, M. T.,, A. G. Maier,, T. Triglia,, and A. F. Cowman. 2003. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 100: 4796 4801.
153. Eaton, M. D. 1938. The agglutination of Plasmodium knowlesi by immune serum. J. Exp. Med. 67: 857.
154. Eaton, M. D. 1939. The soluble malarial antigen in the serum of monkeys infected with Plasmodium knowlesi. J. Exp. Med. 69: 517 532.
155. Eaton, M. D.,, and L. T. Coggeshall. 1939. Production in monkeys of complement fixing antibodies without active immunity by injection of killed Plasmodium knowlesi. J. Exp. Med. 70: 141 146.
156. Eda, S.,, J. Lawler,, and I. W. Sherman. 1999. Plasmodium falciparuminfected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein. Mol. Biochem. Parasitol. 100: 195 205.
157. Eda, S.,, and I. W. Sherman. 2004. Plasmodium falciparum-infected erythrocytes bind to the RGD motif of fibronectin via the band 3-related adhesin. Exp. Parasitol. 107: 157 162.
158. Eisen, H. N. 2001. Michael Heidelberger 1888–1991. Biogra. Mem. Natl. Acad. Sci. 80: 122 140.
159. Ellis, J.,, L. S. Ozaki,, R. W. Gwadz,, A. H. Cochrane,, V. Nussenzweig,, R. S. Nussenzweig,, and G. N. Godson. 1983. Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature 302: 536 538.
160. Enea, V.,, D. Arnot,, E. C. Schmidt,, A. Cochrane,, R. Gwadz,, and R. S. Nussenzweig. 1984. Circumsporozoite gene of Plasmodium cynomolgi (Gombak): cDNA cloning and expression of the repetitive circumsporozoite epitope. Proc. Natl. Acad. Sci. USA 81: 7520 7524.
161. Epstein, J. E. 2007. What will a partly protective malaria vaccine mean to mothers in Africa? Lancet 370: 1523 1524.
162. Epstein, J. E.,, B. Giersing,, G. Mullen,, V. Moorthy,, and T. L. Richie. 2007. Malaria vaccines: are we getting closer? Curr. Opin. Mol. Ther. 9: 12 24.
163. Epstein, J. E.,, S. Rao,, F. Williams,, D. Freilich,, T. Luke,, M. Sedegah,, P. de la Vega,, J. Sacci,, T. L. Richie,, and S. L. Hoffman. 2007. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J. Infect. Dis. 196: 145 154.
164. Espinal, C.,, E. Moreno,, J. Umana,, J. Ramirez,, and M. Montilla. 1984. Susceptibility of different populations of Colombian Aotus monkeys to the FCB-1 strain of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 33: 777 782.
165. Eugui, E. M.,, and A. C. Allison. 1979. Malaria infections in different strains of mice and their correlation with natural killer activity. Bull. W. H. O. 57 ( Suppl. 1): 231 238.
166. Eyles, D. 1952. Studies on Plasmodium gallinaceum. I. Factors associated with the malaria infection in the vertebrate host which influence the degree of infection in the mosquito. Am. J. Hyg. 55: 386 391.
167. Eyles, D. 1952. Studies on Plasmodium gallinaceum. II. Factors in the blood of the vertebrate host influencing mosquito infection. Am. J. Hyg. 55: 276 290.
168. Fairhurst, R. M.,, H. Fujioka,, K. Hayton,, K. F. Collins,, and T. E. Wellems. 2003. Aberrant development of Plasmodium falciparumI n hemoglobin CC red cells: implications for the malaria protective effect of the homozygous state. Blood 101: 3309 3315.
169. Fleischer, B. 2004. 100 years ago: Giemsa's solution of staining plasmodia. Trop. Med. Inter. Health 9: 755 756.
170. Fortin, A.,, M. M. Stevenson,, and P. Gros. 2002. Susceptibility to malaria as a complex trait: big pressure from a tiny creature. Hum. Mol. Genet. 11: 2469 2478.
171. Franke-Fayard, B.,, C. J. Janse,, M. Cunha-Rodrigues,, J. Ramesar,, P. Buscher,, I. Que,, C. Lowik,, P. J. Voshol,, M. A. den Boer,, S. G. van Duinen,, M. Febbraio,, M. M. Mota,, and A. P. Waters. 2005. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. USA 102: 11468 11473.
172. Freeman, R. R.,, A. J. Trejdosiewicz,, and G. A. Cross. 1980. Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite. Nature 284: 366 368.
173. Freund, J.,, K. J. Thomson,, H. E. Sommer,, A. W. Walter,, and E. L. Schenkein. 1945. Immunization of Rhesus monkeys against malarial infection ( P. knowlesi) with killed parasites and adjuvants. Science 102: 202 204.
174. Freund, J.,, K. Thomson,, H. Sommer,, A. Walter,, and T. Pisani. 1948. Immunization of monkeys against malaria by means of killed parasites with adjuvants. Am. J. Trop. Med. 28: 1 22.
175. Freund, J. S.,, H. Sommer,, and A. Walter. 1945. Immunization against malaria: vaccination of ducks with killed parasites incorporated with adjuvants. Science 102: 200 202.
176. Frevert, U.,, and E. Nardin. 2008. Cellular effector mechanisms against Plasmodium liver stages. Cell. Microbiol. 10: 1956 1967.
177. Fried, M.,, K. K. Hixson,, L. Anderson,, Y. Ogata,, T. K. Mutabingwa,, and P. E. Duffy. 2007. The distinct proteome of placental malaria parasites. Mol. Biochem. Parasitol. 155: 57 65.
178. Fried, M.,, F. Nosten,, A. Brockman,, B. J. Brabin,, and P. E. Duffy. 1998. Maternal antibodies block malaria. Nature 395: 851 852.
179. Galinski, M. R.,, A. R. Dluzewski,, and J. W. Barnwell,. 2005. A mechanistic approach to merozoite invasion of red blood cells: merozoite biogenesis, rupture, and invasion of erythrocytes, p. 113 168. In I. W. Sherman (ed.), Molecular Approaches to Malaria. ASM Press, Washington, DC.
180. Gamage-Mendis, A. C.,, J. Rajakaruna,, R. Carter,, and K. N. Mendis. 1992. Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka. Parasite Immunol. 14: 385 396.
181. Gardner, M. J.,, N. Hall,, E. Fung,, O. White,, M. Berriman,, R. W. Hyman,, J. M. Carlton,, A. Pain,, K. E. Nelson,, S. Bowman,, I. T. Paulsen,, K. James,, J. A. Eisen,, K. Rutherford,, S. L. Salzberg,, A. Craig,, S. Kyes,, M. S. Chan,, V. Nene,, S. J. Shallom,, B. Suh,, J. Peterson,, S. Angiuoli,, M. Pertea,, J. Allen,, J. Selengut,, D. Haft,, M. W. Mather,, A. B. Vaidya,, D. M. Martin,, A. H. Fairlamb,, M. J. Fraunholz,, D. S. Roos,, S. A. Ralph,, G. I. McFadden,, L. M. Cummings,, G. M. Subramanian,, C. Mungall,, J. C. Venter,, D. J. Carucci,, S. L. Hoffman,, C. Newbold,, R. W. Davis,, C. M. Fraser,, and B. Barrell. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419: 498 511.
182. Garnham, P. C. C. 1947. Exo-erythrocytic schizogony in Plasmodium kochi: a preliminary note. Trans. R. Soc. Trop. Med. Hyg. 40: 719 722.
183. Gaur, D.,, J. R. Storry,, M. E. Reid,, J. W. Barnwell,, and L. H. Miller. 2003. Plasmodium falciparumis able to invade erythrocytes through a trypsin-resistant pathway independent of glycophorin B. Infect. Immun. 71: 6742 6746.
184. Geiman, Q. M.,, and M. J. Meagher. 1967. Susceptibility of a New World monkey to Plasmodium falciparumf rom man. Nature 215: 437 439.
185. Geison, G. 1990. Pasteur, Roux and rabies: scientific versus clinical mentalities. J. Hist. Med. Allied Sci. 45: 341 365.
186. Geison, G. 1978. Pasteur's work on rabies: re-examining the ethical issues. Hastings Center Rep. 8: 26 33.
187. Geison, G. 1995. The Private Science of Louis Pasteur. Princeton University Press, Princeton, NJ.
188. Good, M. F. 2005. Vaccine-induced immunity to malaria parasites and the need for novel strategies. Trends Parasitol. 21: 29 34.
189. Good, M. F.,, and D. L. Doolan. 1999. Immune effector mechanisms in malaria. Curr. Opin. Immunol. 11: 412 419.
190. Good, M. F.,, and D. L. Doolan. 2007. Malaria's journey through the lymph node. Nat. Med. 13: 1023 1024.
191. Gordon, D. M.,, T. W. McGovern,, U. Krzych,, J. C. Cohen,, I. Schneider,, R. LaChance,, D. G. Heppner,, G. Yuan,, M. Hollingdale,, M. Slaoui, et al. 1995. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite proteinhepatitis B surface antigen subunit vaccine. J. Infect. Dis. 171: 1576 1585.
192. Grabowsky, M. 2008. The billion dollar malaria moment. Nature 451: 1051 1052.
193. Gratepanche, S.,, B. Gamain,, J. D. Smith,, B. A. Robinson,, A. Saul,, and L. H. Miller. 2003. Induction of crossreactive antibodies against the Plasmodium falciparum variant protein. Proc. Natl. Acad. Sci. USA 100: 13007 13012.
194. Graves, P.,, H. Gelband,, and P. Garner. 1998. The SPf66 malaria vaccine: what is the evidence for efficacy? Parasitol. Today 14: 218 220.
195. Graves, P. M. 1998. Comparison of the cost-effectiveness of vaccines and insecticide impregnation of mosquito nets for the prevention of malaria. Ann. Trop. Med. Parasitol. 92: 399 410.
196. Graves, P. M.,, R. Carter,, T. R. Burkot,, I. A. Quakyi,, and N. Kumar. 1988. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol. 10: 209 218.
197. Greenwood, B. M.,, K. Bojang,, C. Whitty,, and G. Targett. 2005. Malaria. Lancet 365: 1487 1498.
198. Grotendorst, C. A.,, N. Kumar,, R. Carter,, and D. C. Kaushal. 1984. A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies. Infect. Immun. 45: 775 777.
199. Gruenberg, J.,, D. R. Allred,, and I. W. Sherman. 1983. Scanning electron microscope-analysis of the protrusions (knobs) present on the surface of Plasmodium falciparum-infected erythrocytes. J. Cell Biol. 97: 795 802.
200. Grun, J.,, and W. Weidanz. 1983. Antibody-independent immunity to reinfection malaria in B cell deficient mice. Infect. Immun. 41: 1197 1204.
201. Gruner, A. C.,, M. Mauduit,, R. Tewari,, J. F. Romero,, N. Depinay,, M. Kayibanda,, E. Lallemand,, J. M. Chavatte,, A. Crisanti,, P. Sinnis,, D. Mazier,, G. Corradin,, G. Snounou,, and L. Renia. 2007. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS ONE 2: e1371.
202. Guerin-Marchand, C.,, P. Druilhe,, B. Galey,, A. Londono,, J. Patarapotikul,, R. L. Beaudoin,, C. Dubeaux,, A. Tartar,, O. Mercereau-Puijalon,, and G. Langsley. 1987. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329: 164 167.
203. Guillemin, J. 2002. Choosing scientific patrimony: Sir Ronald Ross, Alphonse Laveran and the mosquito hypothesis for malaria. J. Hist. Med. 57: 385 409.
204. Gwadz, R. W. 1976. Successful immunization against the sexual stages of Plasmodium gallinaceum. Science 193: 1150 1151.
205. Gwadz, R. W.,, and L. C. Koontz. 1984. Plasmodium knowlesi: persistence of transmission blocking immunity in monkeys immunized with gamete antigens. Infect. Immun. 44: 137 140.
206. Gysin, J., 1998. Animal models: primates, p. 419 441. In I. W. Sherman (ed.), Malaria. Parasite Biology, Pathognesis and Protection. ASM Press, Washington, DC.
207. Gysin, J.,, M. Hommel,, and L. P. da Silva. 1980. Experimental infection of the squirrel monkey ( Saimiri sciureus) with Plasmodium falciparum. J. Parasitol. 66: 1003 1009.
208. Hadley, T. J.,, and L. H. Miller. 1988. Invasion of erythrocytes by malaria parasites: erythrocyte ligands and parasite receptors. Prog. Allergy 41: 49 71.
209. Hafalla, J. C.,, A. Morrot,, G. Sano,, G. Milon,, J. J. Lafaille,, and F. Zavala. 2003. Early self-regulatory mechanisms control the magnitude of CD8 + T cell responses against liver stages of murine malaria. J. Immunol. 171: 964 970.
210. Hafalla, J. C.,, G. Sano,, L. H. Carvalho,, A. Morrot,, and F. Zavala. 2002. Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages. Proc. Natl. Acad. Sci. USA 99: 11819 11824.
211. Harris, P. K.,, S. Yeoh,, A. R. Dluzewski,, R. A. O'Donnell,, C. Withers-Martinez,, F. Hackett,, L. H. Bannister,, G. H. Mitchell,, and M. J. Blackman. 2005. Molecular identification of a malaria merozoite surface sheddase. PLoS Pathog. 1: 241 251.
212. Harrison, G. 1978. Mosquitoes, Malaria and Man: a History of Hostilities since 1880. Dutton, New York, NY.
213. Haynes, J. D.,, C. L. Diggs,, F. A. Hines,, and R. E. Desjardins. 1976. Culture of human malaria parasites Plasmodium falciparum. Nature 263: 767 769.
214. Heidelberger, M.,, W. A. Coates,, and M. Mayer. 1946. Studies in human malaria. II. Attempts to influence relapsing vivax malaria by treatment of patients with vaccine ( P. vivax). J. Immunol. 52: 101 107.
215. Heidelberger, M.,, M. Mayer,, and C. Demarest. 1946. Studies in human malaria. I. The preparation of vaccines and suspensions containing plasmodia. J. Immunol. 52: 325 330.
216. Heidelberger, M.,, C. Prout,, J. Hindle,, and A. Rose. 1946. Studies in human malaria. III. An attempt at vaccination of paretics against blood-borne infection with Plasmodium vivax. J. Immunol. 52: 109 118.
216a. Heidelberger, M.,, M. Mayer,, A. Alving,, B. Craige,, R. Jones,, T. Pullman,, and M. Whorton. 1946. Studies in human malaria. IV. An attempt at vaccination of volunteers against mosquito-borne infection with Pl. vivax. J. Immunol. 52: 113 118.
217. Heppner, D. G.,, D. M. Gordon,, M. Gross,, B. Wellde,, W. Leitner,, U. Krzych,, I. Schneider,, R. A. Wirtz,, R. L. Richards,, A. Trofa,, T. Hall,, J. C. Sadoff,, P. Boerger,, C. R. Alving,, D. R. Sylvester,, T. G. Porter,, and W. R. Ballou. 1996. Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes. J. Infect. Dis. 174: 361 366.
218. Heppner, D. G., Jr.,, K. E. Kester,, C. F. Ockenhouse,, N. Tornieporth,, O. Ofori,, J. A. Lyon,, V. A. Stewart,, P. Dubois,, D. E. Lanar,, U. Krzych,, P. Moris,, E. Angov,, J. F. Cummings,, A. Leach,, B. T. Hall,, S. Dutta,, R. Schwenk,, C. Hillier,, A. Barbosa,, L. A. Ware,, L. Nair,, C. A. Darko,, M. R. Withers,, B. Ogutu,, M. E. Polhemus,, M. Fukuda,, S. Pichyangkul,, M. Gettyacamin,, C. Diggs,, L. Soisson,, J. Milman,, M. C. Dubois,, N. Garcon,, K. Tucker,, J. Wittes,, C. V. Plowe,, M. A. Thera,, O. K. Duombo,, M. G. Pau,, J. Goudsmit,, W. R. Ballou,, and J. Cohen. 2005. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 23: 2243 2250.
219. Herrera, S.,, B. L. Perlaza,, A. Bonelo,, and M. Arevalo-Herrera. 2002. Aotus monkeys: their great value for anti-malaria vaccines and drug testing. Int. J. Parasitol. 32: 1625 1635.
220. Herrington, D.,, J. Davis,, E. Nardin,, M. Beier,, J. Cortese,, H. Eddy,, G. Losonsky,, M. Hollingdale,, M. Sztein,, M. Levine, et al. 1991. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am. J. Trop. Med. Hyg. 45: 539 547.
221. Herrington, D. A.,, E. H. Nardin,, G. Losonsky,, I. C. Bathurst,, P. J. Barr,, M. R. Hollingdale,, R. Edelman,, and M. M. Levine. 1991. Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. Am. J. Trop. Med. Hyg. 45: 695 701.
222. Hillier, C. J.,, L. A. Ware,, A. Barbosa,, E. Angov,, J. A. Lyon,, D. G. Heppner,, and D. E. Lanar. 2005. Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. Infect. Immun. 73: 2109 2115.
223. Hoffman, S. L.,, E. D. Franke,, M. R. Hollingdale,, and P. Druilhe,. 1996. Attacking the infected hepatocyte, p. 35 75. In S. Hoffman (ed.), Malaria Vaccine Development: a Multi-Immune Response Approach. ASM Press, Washington, DC.
224. Hoffman, S. L.,, L. M. Goh,, T. C. Luke,, I. Schneider,, T. P. Le,, D. L. Doolan,, J. Sacci,, P. de la Vega,, M. Dowler,, C. Paul,, D. M. Gordon,, J. A. Stoute,, L. W. Church,, M. Sedegah,, D. G. Heppner,, W. R. Ballou,, and T. L. Richie. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185: 1155 1164.
225. Hoffman, S. L.,, M. Sedegah,, and R. C. Hedstrom. 1994. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine 12: 1529 1533.
226. Hogh, B.,, E. Petersen,, I. Crandall,, A. Gottschau,, and I. W. Sherman. 1994. Immune responses to band 3 neoantigens on Plasmodium falciparum-infected erythrocytes in subjects living in an area of intense malaria transmission are associated with low parasite density and high hematocrit value. Infect. Immun. 62: 4362 4366.
227. Holbrook, T., 1980. Immunizatioin against exo-erythrocytic stages of malaria parasites, p. 203 230. In J. Kreier (ed.), Malaria, vol. 3. Academic Press, San Diego, CA.
228. Holder, A. A.,, and R. R. Freeman. 1982. Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. J. Exp. Med. 156: 1528 1538.
229. Holder, A. A.,, and R. R. Freeman. 1981. Immunization against blood-stage rodent malaria using purified parasite antigens. Nature 294: 361 364.
230. Holder, A. A.,, R. R. Freeman,, and S. C. Nicholls. 1988. Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol. 10: 607 617.
231. Holder, A. A.,, J. A. Guevara Patino,, C. Uthaipibull,, S. E. Syed,, I. T. Ling,, T. Scott-Finnigan,, and M. J. Blackman. 1999. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parasitologia 41: 409 414.
232. Hollingdale, M. R.,, and U. Krzych. 2002. Immune responses to liver-stage parasites: implications for vaccine development. Chem. Immunol. 80: 97 124.
233. Hollingdale, M. R.,, J. L. Leef,, M. McCullough,, and R. L. Beaudoin. 1981. In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei from sporozoites. Science 213: 1021 1022.
234. Hollingdale, M. R.,, P. Leland,, and A. L. Schwartz. 1983. In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei in a hepatoma cell line. Am. J. Trop. Med. Hyg. 32: 682 684.
235. Holmes, O. W. 1909–1914. The Contagiousness of Puerperal Fever. P. F. Collier, New York, NY.
236. Hopkin, M. 2008. Malaria: the big push. Nature 451: 1047 1049.
237. Howard, R. F.,, and R. T. Reese. 1990. Plasmodium falciparum: heterooligomeric complexes of rhoptry polypeptides. Exp. Parasitol. 71: 330 342.
238. Howard, R. F.,, H. A. Stanley,, and R. T. Reese. 1988. Characterization of a high-molecular-weight phosphoprotein synthesized by the human malarial parasite Plasmodium falciparum. Gene 64: 65 75.
239. Howard, R. F.,, A. Varki,, and R. T. Reese. 1984. Merozoite proteins synthesized in P. falciparum schizonts. Prog. Clin. Biol. Res. 155: 45 61.
240. Howard, R. J. 1984. Antigenic variation of bloodstage malaria parasites. Philos. Trans. R. Soc. Lond. Ser. B 307: 141 158.
241. Howard, R. J.,, J. W. Barnwell,, and V. Kao. 1983. Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes. Proc. Natl. Acad. Sci. USA 80: 4129 4133.
242. Howard, R. J.,, J. W. Barnwell,, V. Kao,, W. A. Daniel,, and S. B. Aley. 1982. Radioiodination of new protein antigens on the surface of Plasmodium knowlesi schizont-infected erythrocytes. Mol. Biochem. Parasitol. 6: 343